People

The People

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, percentages, share counts and multiples are unitless and unchanged.

Governance grade: C. The founder-CEO holds 53.6% of the vote on just 13.7% of the capital, three of the four independent directors only joined at the IPO eight months ago, and FY2024 director pay jumped 460% on IPO-vesting share grants — a structurally minority-shareholder-unfriendly setup that is offset, but not fixed, by genuinely deep technical leadership and strategic alignment with key OEM customers.

1. The People Running This Company

Horizon is a founder-led, technically deep, Baidu-pedigreed leadership team. Founder Dr. Kai Yu started the company in 2015 after running Baidu Research and initiating Baidu's autonomous driving programme; CTO Dr. Chang Huang was his Baidu chief R&D architect; COO Annie Tao came from Baidu USA. The 2024 addition of Dr. Liming Chen — three decades in Bosch's Chassis Systems Control China — was the deliberate hire of an OEM-fluent operator to professionalise the customer-facing organisation as Horizon ramped from R&D shop to mass-production supplier. The team is young (founders aged 39–48) and equity-incentivised but otherwise has limited public-company experience: this is the first listed CEO seat any of them has held.

Dr. Kai Yu (founder/CEO/Chair, 48). PhD Computer Science, U of Munich; ran Baidu Research; initiated Baidu's autonomous driving. The capability case is strong; the governance question is that he combines the Chairman and CEO roles (a Code C.2.1 deviation), sits on the Remuneration and Nomination committees, and controls 54% of votes via a family trust. This is a founder-controlled company in the literal sense.

Dr. Chang Huang (co-founder/CTO, 44). Chief R&D architect at Baidu, 80+ patents — credible chief architect for the Journey chip family. Voting stake of 12% gives him a real seat at the table.

Dr. Liming Chen (President, 62, joined 2021, named ED 2024). Thirty years at Bosch Group, most recently SVP and Regional President of Bosch Chassis Systems Control China. The most decision-useful hire on the bench: he brings tier-1 supplier relationships and mass-production discipline that the founder team did not have. Replaces Yufeng Zhang (former auto BU head) who resigned in March 2024.

Lei Wang (CFO). Named in third-party listings; not yet a board director. CFO turnover risk is the main succession question — Tao Jiang was previously cited as CFO and has since been replaced. For a recently-listed loss-making company, CFO instability deserves monitoring.

2. What They Get Paid

Total director compensation went from $2.4M in FY2023 to $13.0M in FY2024 — a 460% jump that is almost entirely an IPO-vesting one-off. Cash pay is modest (founders earn roughly $0.3–0.4M wages each); 82% of FY2024 director comp was share-based. Dr. Kai Yu alone took $8.0M in share-based comp, almost all of which is the recognition of pre-IPO 2018-plan awards crystallising at the October 2024 listing. The pay structure is therefore equity-loaded, performance-untethered in any explicit sense, and pre-set — not a board-negotiated reward for FY24 results. INED fees are minimal (~$11k each), which is low even by HK standards and may limit how aggressively new INEDs push back.

For a company that lost roughly $270M at the EBIT level in FY2024 on $327M of revenue, $8.0M of CEO equity comp in one year is not outrageous in absolute terms — it is roughly 2.4% of revenue, mostly IPO catch-up, and it crystallises a paper grant the founder has effectively been carrying since 2018. The bigger question is the stock of pending awards: Dr. Kai Yu is entitled to up to 71.9 million additional Class B shares under the 2018 plan (worth around $58M at current prices), and a fresh Post-IPO Share Incentive Plan was adopted at listing. Pay is not pegged to operating performance metrics — vesting is largely time- and listing-event-driven.

3. Are They Aligned?

This is the section that decides the case. The summary: insiders own a lot, vote even more, have not sold meaningfully, and the family is trust-locked — but the share count is growing fast through grants and top-up placements, and a WVR structure that gives the founder 4x voting leverage means alignment is structurally one-directional.

Ownership and control

The four-founder bloc owns roughly 18% of capital and controls roughly 66% of votes. Volkswagen (15% capital, ~9% voting via Class B only) and SAIC (7.8%) are both customers, customers' parents, and joint-venture partners — so a meaningful share of the float is held by counter-parties whose commercial relationship with Horizon could conflict with their fiduciary interest as shareholders. Public float in the conventional sense (institutions plus retail unconnected to OEMs or 5Y) is roughly 40% of capital and only ~8% of votes. Outside shareholders cannot win a contested vote on any non-Reserved Matter.

Insider buying / selling

Founder Dr. Kai Yu has not sold any shares post-IPO; co-founders Huang and Tao have not sold either. The small executive-officer sales by Jian Xu and Liming Chen in early 2026 are immaterial (totalling under $0.5M) and consistent with personal liquidity rather than a directional signal. Lock-ups on the founder shares run beyond the typical 12-month IPO restriction because the holdings sit in family trusts.

Dilution

Shares outstanding have risen by roughly 10.9% in 18 months post-IPO. Most of that is the two top-up placements; recurring SBC grants add another 0.5–1% per year. Set against approximately $1.0–1.4B of cash on balance sheet, dilution is the chosen funding model — Horizon is using equity, not debt, to bridge to profitability, and ESOP issuance is aggressive (two employee shareholding platforms already hold 10.95% of capital). For an outside shareholder, EPS and per-share fair-value targets need to flex for a 3–5% per-year dilution headwind.

Related-party behaviour

Two flagged continuing connected transactions, both small and both ring-fenced through Listing Rule procedures:

• Product Solutions Sales Framework with D-Robotics (HZ subsidiary; connected because four directors hold over 10% of D-Robotics voting): annual cap $5.1M for FY24, actual $5.1M — used in full but within cap.
• R&D Services Framework with D-Robotics: annual cap $0.3M for FY24, actual $0.2M. Sunsetting end of 2024.
• CARIZON JV with Volkswagen: only related-party customer/supplier overlap flagged in the Directors' Report. Mechanical: VW funds via a $800M convertible loan (now amended at HK$3.99 conversion) and CARIZON purchases solutions from HZ at arm's length.

PwC HK confirmed in its 14A.56 letter that the connected transactions stayed within their caps and on agreed pricing terms. No transactions of obviously self-dealing character were disclosed. Auditor is PwC HK; legal adviser Davis Polk; compliance adviser Somerley — all top-tier counterparties.

Capital allocation

The company is loss-making at the EBIT level (FY24 operating loss around $270M), funded by IPO proceeds ($691M raised in October 2024) and the two 2025 placements (~$1.0B combined). There has been no buyback, no dividend, and no M&A of note. The capital allocation policy is: spend on R&D, dilute as needed, ride to scale. That is a normal and arguably correct stance for a pre-profit chip-designer, but it leaves shareholders with no near-term cash return and steady dilution.

Skin in the game

A 7/10: founders hold meaningful economic stakes (~18% combined) and are trust-locked, no founder selling, no related-party self-dealing of substance. The deduction is the WVR structure (alignment runs through the founder's eyes, not pro-rata shareholders) and the dilution machine that converts shareholder equity into runway cash.

4. Board Quality

Twelve directors, 33.3% independent — the bare minimum under HKEX rules for a WVR issuer. All four NEDs are appointees of strategic shareholders (Hillhouse, 5Y, CARIAD/VW, SAIC) — not independent in substance but disclosed correctly as non-executive. Three of the four INEDs joined only in October 2024 at the listing, so the audit and nomination committee chairs (Pu and Wu) have around 18 months of institutional history with the company. Only Dr. Ya-Qin Zhang (former Baidu President, ex-Microsoft China Chair) has any operating history pre-IPO.

5. The Verdict

Governance Grade: C

Grade: C. A founder-controlled, technically credible, strategically well-connected team operating under a governance framework that prioritises long-horizon founder vision over minority-shareholder protections. Nothing in the filings, the auditor letter, or the year of post-IPO trading suggests self-dealing or earnings manipulation; the strategic-shareholder board adds genuine industry value; the founder has real skin in the game. But the weighted voting structure, the bare-minimum-and-mostly-new INED bench, the founder's presence on the Rem and Nom committees, and the use of dilutive top-up placements rather than measured equity issuance mean an outside shareholder is along for the ride, not at the table.

Strongest positives. (1) Founder/CTO are credible AI/AV operators with deep economic stakes and trust-locked positions. (2) Strategic shareholders (VW 15%, SAIC 8%) are both customers and capital — alignment is real. (3) PwC HK auditor, Davis Polk counsel, clean 14A.56 confirmation on connected transactions. (4) Cash compensation is modest; pay is equity-loaded and reflects an IPO event, not ongoing largesse.

Real concerns. (1) WVR gives the founder 4x voting leverage and combines Chair/CEO; he sits on the committees that decide his own pay. (2) Three of four INEDs joined only at the IPO — including the Audit and Nomination chairs. (3) Two top-up placements in 2025 (combined around $1.0B) added roughly 8% dilution; the Post-IPO Share Incentive Plan layers on more. (4) Pay-for-performance is essentially absent — comp is calendar-and-event vesting, not metric-tied. (5) CFO turnover (Tao Jiang to Lei Wang) in a still-loss-making capital-markets-active business deserves monitoring.

What would move the grade.

Upgrade to B- would require an external INED majority on the Rem committee, removal of the founder from at least one of Rem or Nom, and an explicit operating-metric vesting overlay on the Post-IPO Plan. Two clean audit cycles with no auditor caveats and a slowdown of dilutive issuance would help.

Downgrade to D would follow a related-party transaction outside the existing D-Robotics / CARIZON ring-fence (e.g., a related-party acquisition above the 5% Listing Rules threshold), a Class A voting expansion, a third dilutive placement without commensurate cash generation, or any concentrated executive-officer selling once founder lock-ups roll off.